GenovisQ1 2024: Financials in line with expectations, strong outlook - Redeye

Redeye sees a Q1 report from Genovis largely aligning with our estimates with minor deviation on the downside for sales and upside for EBIT. The share currently slightly above our bear case, but for how long?

Länk till analysen i sin helhet: https://www.redeye.se/research/1008120/genovis-q1-2024-financials-in-line-positive-outlook-for-the-share-price?utm_source=finwire&utm_medium=RSS